Insights

This Figure has Direct Correlation to Mortality

December 28, 2018

A Disease Results from Genetic and Environmental Factors

December 27, 2018

Tumor Micro-environment and Development of Biology Medicine

December 27, 2018

A Lab with 29 Nobel Prizes

December 27, 2018

1/2
Please reload

​Topic 1: Translational Medicine

Moderators

 

DENG Shaoping, President, Sichuan Academy of Medical Science & Sichuan Provincial People’s Hospital
SHI Yuankai, Vice President, Chinese Academy of Medical Science Cancer Hospital, National Lab for Cancer Clinical Trials

Industry Fellow, Royal Society, United Kingdom

ZHANG Xiangcheng

Vice President, Sichuan Academy of Medical Science & Sichuan Provincial People’s Hospital

YANG Zhenglin

Professor, Sichuan University

YANG Shengyong

Professor of Medicine and Physiology in the Mayo Medical School; Director of the Renovascular Research Laboratory, and Head of the Nephrology Research Unit at the Division of Nephrology & Hypertension at Mayo Clinic

Lilach O. Lerman

​Topic 2: Precision Medicine

Moderators

 

RAO Keqin, Vice President and Chairman, Chinese Medical Association; President, Chinese Health Economics Association
WU Qi, Human Resources and Social Security Department of Sichuan

Director of State Key Laboratory of Biotherapy and Cancer

Center, West China Hospital, Sichuan University; Academician, Chinese Academy of Sciences

WEI Yuquan

President, International Richland Hospital, Kunming, Yunnan

XU Mei

Vice President, Chinese Academy of Medical Science Cancer Hospital, National Lab for Cancer Clinical Trials

SHI Yuankai

President, Mevion Medical Systems, Boston, U.S.

James Meng

Clinical Pharmacist, Pharmacoepidemiologist, and

Health Policy Researcher, Department of Population Medicine of Harvard Medical School & Harvard Pilgrim Health Care Institute

Anita Katharina Wagner

Panel Discussion

Moderator: 


MA Jing, Director, China Center, Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care InstituteHE Xin, Managing Partner, Hyfinity Investments

Above Speakers

 

SHI Anli, President, Cancer Rehabilitation Society of China Anti-Cancer Association